{
    "clinical_study": {
        "@rank": "84002", 
        "acronym": "CULPRIT-SHOCK", 
        "arm_group": [
            {
                "arm_group_label": "Immediate multivessel PCI", 
                "arm_group_type": "Active Comparator", 
                "description": "After diagnostic angiography the culprit lesion is identified and PCI should be performed using standard techniques. The use of drug-eluting stents is recommended but not mandatory. All additional lesions in other major coronary arteries defined by a diameter >2 mm with high grade stenoses (>70% by visual assessment) should be intervened using standard techniques. Other major coronary arteries are defined by stenoses of other vessels and are not confined to a diagonal branch if the left anterior descending coronary artery was identified as the culprit lesion."
            }, 
            {
                "arm_group_label": "Culprit lesion only PCI", 
                "arm_group_type": "Active Comparator", 
                "description": "After diagnostic angiography the culprit lesion is identified and PCI of the culprit lesion should be performed using standard techniques. The use of drug-eluting stents is recommended but not mandatory. All other lesions should be left untreated in the acute setting. Complete revascularization of the non-culprit lesions may be performed at a later time point as staged procedure depending on remaining ischemia (as per guideline recommendations either by PCI or CABG)."
            }
        ], 
        "brief_summary": {
            "textblock": "The study compares the therapies of instant multivessel balloon angioplasty plus stent\n      implantation or the balloon angioplasty plus stent implantation of the infarct artery alone\n      with any possible graduated later treatment of the other vessels in patients with acute\n      myocardial infarction with cardioganic shock.\n\n      The main study hypothesis is to explore if culprit vessel only PCI with potentially\n      subsequent staged revascularization in comparison to immediate multivessel revascularization\n      by PCI in patients with cardiogenic shock complicating acute myocardial infarction reduces\n      the incidence of 30- day mortality and/or severe renal failure requiring renal replacement\n      therapy."
        }, 
        "brief_title": "Culprit Lesion Only PCI Versus Multivessel PCI in Cardiogenic Shock", 
        "completion_date": {
            "#text": "December 2016", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Cardiogenic Shock", 
            "Acute Myocardial Infarction", 
            "Complications"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Infarction", 
                "Myocardial Infarction", 
                "Shock", 
                "Shock, Cardiogenic"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        Cardiogenic shock complicating acute myocardial infarction (STEMI or NSTEMI) with\n        obligatory:\n\n        I) Planned early revascularization by PCI II) Multivessel coronary artery disease defined\n        as more than 70% stenosis in at least 2 major vessels (more than 2 mm diameter) with\n        identifiable culprit lesion III)\n\n          1. Systolic blood pressure less than 90 mmHg for more than 30 min or\n\n          2. catecholamines required to maintain pressure more than 90 mmHg during systole and IV)\n             Signs of pulmonary congestion V) Signs of impaired organ perfusion with at least one\n             of the following criteria\n\n        a) Altered mental status b) Cold, clammy skin and extremities c) Oliguria with urine\n        output less than 30 ml/h d) Serum-lactate more than 2.0 mmol/l VI) Informed consent\n\n        Exclusion Criteria:\n\n          -  Resuscitation more than 30 minutes\n\n          -  No intrinsic heart action\n\n          -  Cerebral deficit with fixed dilated pupils (not drug-induced)\n\n          -  Need for primary urgent bypass surgery (to be determined after diagnostic\n             angiography)\n\n          -  Single vessel disease\n\n          -  Mechanical cause of cardiogenic shock\n\n          -  Onset of shock more than 12 h\n\n          -  Massive lung emboli\n\n          -  Age more than 90 years\n\n          -  Shock of other cause (bradycardia, sepsis, hypovolemia, etc.)\n\n          -  Other severe concomitant disease with limited life expectancy <6 months\n\n          -  Pregnancy\n\n          -  Known severe renal insufficiency (creatinine clearance <30 ml/kg)"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "90 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "706", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "August 14, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01927549", 
            "org_study_id": "CULPRIT-SHOCK1.2"
        }, 
        "intervention": [
            {
                "arm_group_label": "Immediate multivessel PCI", 
                "intervention_name": "Immediate multivessel PCI", 
                "intervention_type": "Procedure"
            }, 
            {
                "arm_group_label": "Culprit lesion only PCI", 
                "intervention_name": "Culprit Lesion only PCI", 
                "intervention_type": "Procedure"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "cardiogenic shock", 
            "infarction", 
            "multivessel coronary artery disease", 
            "angioplasty"
        ], 
        "lastchanged_date": "March 3, 2014", 
        "link": {
            "description": "eCRF and randomization site", 
            "url": "https://studien.herzinfarktforschung.de/CulpritShock/login?ReturnUrl=%2fculpritshock"
        }, 
        "location": [
            {
                "contact": {
                    "last_name": "Gerd Hasenfuss"
                }, 
                "facility": {
                    "address": {
                        "city": "Goettingen", 
                        "country": "Germany"
                    }, 
                    "name": "University of Goettingen"
                }, 
                "investigator": {
                    "last_name": "Gerd Hasenfuss", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "gerhard.schuler@med.uni-leipzig.de", 
                    "last_name": "Gerhard Schuler, MD", 
                    "phone": "00493418651428"
                }, 
                "facility": {
                    "address": {
                        "city": "Leipzig", 
                        "country": "Germany", 
                        "zip": "04289"
                    }, 
                    "name": "University of Leipzig - Heart Center"
                }, 
                "investigator": [
                    {
                        "last_name": "Georg Fuernau, MD", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Gerhard Schuler, MD", 
                        "role": "Principal Investigator"
                    }
                ], 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "holger.thiele@uksh.de", 
                    "last_name": "Holger Thiele"
                }, 
                "contact_backup": {
                    "email": "renate.domeier@uksh.de", 
                    "last_name": "Renate Domeier"
                }, 
                "facility": {
                    "address": {
                        "city": "Luebeck", 
                        "country": "Germany", 
                        "zip": "23538"
                    }, 
                    "name": "University of Luebeck"
                }, 
                "investigator": [
                    {
                        "last_name": "Steffen Desch", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Holger Thiele", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Kai Mortensen", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "Germany"
        }, 
        "number_of_arms": "2", 
        "official_title": "Prospective Randomized Multicenter Study Comparing Immediate Multivessel Revascularization by PCI Versus Culprit Lesion PCI With Staged Non-culprit Lesion Revascularization in Patients With Acute Myocardial Infarction Complicated by Cardiogenic Shock", 
        "overall_contact": {
            "email": "holger.thiele@uksh.de", 
            "last_name": "Holger Thiele, MD", 
            "phone": "00494515002501"
        }, 
        "overall_official": {
            "affiliation": "University of Leipzig", 
            "last_name": "Holger Thiele, MD", 
            "role": "Study Chair"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Germany: Ethics Commission", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "August 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "30-day mortality and/or severe renal failure requiring renal replacement therapy", 
            "safety_issue": "No", 
            "time_frame": "30 days"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01927549"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University of Luebeck", 
            "investigator_full_name": "Holger Thiele", 
            "investigator_title": "Coordinator", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "measure": "30-day mortality", 
                "safety_issue": "No", 
                "time_frame": "30 days"
            }, 
            {
                "measure": "Requirement of renal replacement therapy", 
                "safety_issue": "No", 
                "time_frame": "30 days"
            }, 
            {
                "measure": "Time to hemodynamic stabilization", 
                "safety_issue": "No", 
                "time_frame": "30 days"
            }, 
            {
                "measure": "Duration of catecholamine therapy", 
                "safety_issue": "No", 
                "time_frame": "30 days"
            }, 
            {
                "measure": "Serial creatinine-level creatinine-clearance", 
                "safety_issue": "No", 
                "time_frame": "30 days"
            }, 
            {
                "measure": "Length of ICU-stay", 
                "safety_issue": "No", 
                "time_frame": "30 days"
            }, 
            {
                "measure": "Serial intensive care scoring (SAPS-II score) until stabilization", 
                "safety_issue": "No", 
                "time_frame": "30 days"
            }, 
            {
                "measure": "Requirement and length of mechanical ventilation", 
                "safety_issue": "No", 
                "time_frame": "30 days"
            }, 
            {
                "measure": "All-cause death within 12 months follow-up", 
                "safety_issue": "No", 
                "time_frame": "12 months"
            }, 
            {
                "measure": "Recurrent infarction within 30-days follow-up", 
                "safety_issue": "No", 
                "time_frame": "30 days"
            }, 
            {
                "measure": "Death or recurrent infarction at 12 months follow-up", 
                "safety_issue": "No", 
                "time_frame": "12 months"
            }, 
            {
                "measure": "Rehospitalization for congestive heart failure within 12 months follow-up", 
                "safety_issue": "No", 
                "time_frame": "12 months"
            }, 
            {
                "measure": "Death/recurrent infarction/rehospitalization for congestive heart failure within 12 months", 
                "safety_issue": "No", 
                "time_frame": "12 months"
            }, 
            {
                "measure": "Need for repeat revascularization (PCI and/or CABG) within 12 months follow-up", 
                "safety_issue": "No", 
                "time_frame": "12 months"
            }, 
            {
                "measure": "Peak creatine kinase level during hospital stay", 
                "safety_issue": "No", 
                "time_frame": "30 days"
            }, 
            {
                "measure": "Quality of life at 6 and 12 months assessed using Euroqol 5D (EQ-5D)", 
                "safety_issue": "No", 
                "time_frame": "12 months"
            }, 
            {
                "measure": "Maximum creatine kinase-MB level", 
                "safety_issue": "No", 
                "time_frame": "30 days"
            }, 
            {
                "measure": "Maximum troponin level", 
                "safety_issue": "No", 
                "time_frame": "30 days"
            }, 
            {
                "measure": "Recurrent infarction within 12 months follow-up", 
                "safety_issue": "No", 
                "time_frame": "12 months"
            }
        ], 
        "source": "University of Luebeck", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "European Commission", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "German Cardiac Society", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "German Heart Research Foundation", 
                    "agency_class": "Other"
                }
            ], 
            "lead_sponsor": {
                "agency": "University of Luebeck", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "April 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "March 2014"
    }
}